Should You Buy ANI Pharmaceuticals Stock Before Q4 Earnings?

Key Takeaways ANI Pharmaceuticals reports Q4 2025 earnings Feb. 27, with sales seen at $233M and EPS at $1.99.ANIP's Cortrophin Gel sales are expected at $114M, driven by 88% year-over-year growth.ANIP trades at 1.98x P/S, below the industry's 2.50x, with growth led by rare disease drugs.ANI Pharmaceuticals (ANIP) is set to report fourth-quarter and full-year 2025 earningson Feb. 27, before the opening bell. The Zacks Consensus Estimate for the quarter’s sales and earnings is pegged at $233 million and $1.9 ...